We are seeking a highly motivated immunologist with a background in molecular biology and/or genomics to join the NeoVax team led by Dr. Patrick Ott at Dana-Farber Cancer Institute. The successful applicant will work on correlative studies of cancer vaccine (NeoVax) clinical trials designed to target personal neoantigens. Experience with laboratory techniques such as flow cytometry and ELISA assays, bulk and single-cell sequencing, along with ability to interpret bioinformatics/genomics data, is highly desired. In addition to having technical skills, the preferred candidate will be comfortable working independently and collaboratively and have strong management and communication skills.
Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
Essential duties include but are not limited to:
Education and Experience
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.